The emergence of long non-coding RNAs in hepatocellular carcinoma: an update.

J Cancer

Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha 410078, P.R. China; Cancer Research Institute, Central South University, Changsha 410078, P.R. China.

Published: June 2018

Hepatocellular carcinoma (HCC) accounting for roughly 90% of all primary liver neoplasms is the sixth most frequent neoplasm and the second prominent reason of tumor fatality worldwide. As regulators of diverse biological processes, long non-coding RNAs (lncRNAs) are involved in onset and development of neoplasms. With the continuous booming of well-featured lncRNAs in HCC from 2016 to now, we reviewed the newly-presented comprehension about the relationship between lncRNAs and HCC in this study. To be specific, we summarized the overview function and study tools of lncRNAs, elaborated the roles of lncRNAs in HCC, and sketched the molecule mechanisms of lncRNAs in HCC. In addition, the application of lncRNAs serving as biomarkers in early diagnosis and outcome prediction of HCC patients was highlighted.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036883PMC
http://dx.doi.org/10.7150/jca.24560DOI Listing

Publication Analysis

Top Keywords

lncrnas hcc
16
long non-coding
8
non-coding rnas
8
hepatocellular carcinoma
8
lncrnas
7
hcc
6
emergence long
4
rnas hepatocellular
4
carcinoma update
4
update hepatocellular
4

Similar Publications

Humans have more than 270,000 lncRNAs. Among these, lncRNA HOXA-AS2 is considered a transformative gene involved in various cellular processes, including cell proliferation, apoptosis, migration, and invasion. Thus, it can be regarded as a potential tumor marker for both diagnosis and prognosis.

View Article and Find Full Text PDF

LINC02987 suppression hepatocellular carcinoma progression by modulating autophagy via the miR-338-3p/ATG12 axis.

Exp Cell Res

December 2024

Oncology Department the Third People's Hospital of Kunming Sixth Affiliated Hospital of Dali University, No.319 Wujing Road, Guandu Area, 650000, China; Yunnan Infectious Disease Clinical Medical Center, China. Electronic address:

Hepatocellular carcinoma (HCC), the most common primary liver cancer, is marked by a high mortality rate, with the misregulation of long non-coding RNAs (LncRNAs) playing a key role in its development. Here, we studied the role of LINC02987 in HCC. We employed bioinformatics tools to identify LncRNAs and miRNAs that exhibit differential expression in HCC.

View Article and Find Full Text PDF

Introduction: The development and progression of Hepatocellular Carcinoma (HCC) is more relevant to immune regulation. Therefore, there is an urgent need to find immune-related molecular markers that can predict the prognosis and immune status of HCC.

Methods: RNA-seq and clinical HCC data from the Cancer Genome Atlas (TCGA) were analyzed for differential expression of microRNA (miRNAs), mRNAs, and lncRNAs.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a serious cancer with a high risk of poor outcomes, and the lncRNA MAPKAPK5-AS1 is identified as an oncogene that aids in HCC cell growth.
  • CAF-EVs (carcinoma-associated fibroblast-derived extracellular vesicles) deliver MAPKAPK5-AS1 to HCC cells, which inhibits SMURF2 and stabilizes TCF12, ultimately promoting HCC cell proliferation by upregulating FOXH1 expression.
  • The study highlights potential new therapeutic targets for HCC treatment by demonstrating the role of CAF-EVs and MAPKAPK5-AS1 in tumor growth dynamics.
View Article and Find Full Text PDF

Objective: Long non-coding RNAs (lncRNAs) participate in the formation, progression, and metastasis of cancer. This study aimed to explore the roles of the lncRNA ST8SIA6 antisense RNA 1 (ST8SIA6-AS1) in tumorigenesis and elucidate the underlying molecular mechanism of its upregulation in hepatocellular carcinoma (HCC).

Material And Methods: A total of 56 in-house pairs of HCC tissues were examined, and ST8SIA6-AS1 levels were determined through real-time polymerase chain reaction (PCR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!